ArticleAnalytical and bioanalytical chemistry2026
Antigen-binding-enhanced divalent nanobody-based immunomagnetic separation coupled with ATP bioluminescence for viable Salmonella detection.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Current Salmonella detection methods are time-consuming or incapable of effectively discriminating viable bacteria from dead cells, restricting their practical applications in food safety monitoring. Thus, in this study, an antigen-binding-enhanced Salmonella divalent nanobody (diVHH) was optimally expressed and chemically conjugated with magnetic beads (MBs). Combined with ATP bioluminescence, a novel strategy was developed for the rapid detection of viable Salmonella. Optimization of prokaryotic expression significantly improved the diVHH yield, with an approximately 2.96-fold enhancement. Then, the diVHH-functionalized MBs achieved capture efficiencies exceeding 90% for multiple tested Salmonella serotypes. By integrating immunomagnetic separation with ATP bioluminescence, the established assay exhibited a linear detection range from 10
Indexed as
Identifiers
42709182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.